Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
04/2005
04/27/2005CN1198838C Antipicornaviral compounds, their prepn. and use
04/27/2005CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone
04/27/2005CN1198820C N-substituted nitrogen heterocyclic compound
04/27/2005CN1198795C N-acyl amino-acid amide prodn. process
04/27/2005CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same
04/27/2005CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina
04/26/2005US6884803 Phenylalkynes
04/21/2005WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
04/21/2005WO2005035499A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
04/21/2005WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof
04/21/2005WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085636 Reacting organoboron compound with oxypiperidine compound
04/21/2005US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease
04/21/2005US20050085516 2-W-diaminocarboxylic acid compounds
04/21/2005US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors
04/21/2005US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders
04/21/2005US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents
04/21/2005US20050085506 Novel gamma secretase inhibitors
04/21/2005US20050085474 difluoroamine compounds
04/21/2005US20050085456 Compounds useful in therapy
04/21/2005CA2541831A1 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
04/20/2005EP1524266A1 Pharmaceutical composition
04/20/2005EP1524265A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
04/20/2005EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/20/2005EP1210330B1 Antibacterial agents
04/20/2005EP0721455B9 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors
04/20/2005CN1608051A Method of resolving amlodipine racemate
04/20/2005CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition
04/19/2005US6881845 Reacting p-fluoroacetophenone with formaldehyde and methylbenzylamine, then hydrogenation, cyclization and reducing to form chemical intermediates for paroxetine and omiloxetine
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/19/2005CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
04/14/2005WO2005034184A2 Lighting elements, devices and methods
04/14/2005WO2005033288A2 Hedgehog pathway antagonists
04/14/2005WO2005033064A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
04/14/2005WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators
04/14/2005WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors
04/14/2005WO2005032479A2 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
04/14/2005WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
04/14/2005WO2005000815A3 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
04/14/2005WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof
04/14/2005US20050080268 Process of preparing O-carbamoyl compounds in the presence of active amine group
04/14/2005US20050080265 Sleep disorders; side effect reduction
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates
04/14/2005US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission
04/14/2005US20050080088 Novel compounds
04/14/2005US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
04/14/2005US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders)
04/14/2005US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
04/14/2005US20050079455 Colour photographic recording material
04/14/2005CA2541303A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
04/13/2005EP1522314A1 Remedies for diseases caused by vascular contraction or dilation
04/13/2005EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists
04/13/2005EP1289955B1 Piperidines for use as orexin receptor antagonists
04/13/2005EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent
04/13/2005CN1606592A Novel flame retarding compounds
04/13/2005CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives
04/13/2005CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists
04/13/2005CN1606442A Treatments for restless legs syndrome
04/13/2005CN1196684C Process for producing N.N'-carbonyl dilactan
04/13/2005CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
04/13/2005CN1196680C Modulators of dopamine neurotransmission
04/12/2005US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
04/12/2005US6878736 Histamine H3 receptor ligands
04/12/2005US6878725 Serine protease inhibitors
04/12/2005US6878724 Polyarylcarboxamides useful as lipid lowering agents
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents
04/12/2005US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
04/12/2005US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/12/2005CA2293247C 4-phenylpiperidine compounds
04/12/2005CA2279817C Process for the preparation of substituted piperidine-epoxides
04/12/2005CA2148421C Process for producing optically pure 1,4-dihydropyridines
04/12/2005CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives
04/12/2005CA2081836C Aromatic amidine derivatives and salts thereof
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030751A2 Dipeptidyl peptidase inhibitors
04/07/2005WO2005030722A1 N-substituted-n-(4-piperidinyl) amide derivative
04/07/2005WO2005030721A1 Piperidine derivative
04/07/2005WO2005030720A1 Piperidine derivative having nmda receptor antagonistic activity
04/07/2005WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces
04/07/2005WO2005000845A3 Bicyclic derivatives as nk-1 and nk-2 antagonists
04/07/2005WO2004113289A3 Glycosidase inhibitors and methods of synthesizing same
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075344 Melanocortin receptor agonists
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050075320 Gamma-secretase inhibitors
04/07/2005US20050075270 Process for preparation of piperidin-2-ylacetic acid
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/06/2005EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
04/06/2005EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1414817B1 substituted isoindoles and the use thereof
04/06/2005EP1212486B1 Chlorohydrin and cationic compounds having high affinity for pulp or paper
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity